# Ganciclovir Implant Study for Cytomegalovirus Retinitis

> **NCT00000118** · PHASE3 · COMPLETED · sponsor: **National Eye Institute (NEI)**

## Conditions studied

- HIV Infections
- Acquired Immunodeficiency Syndrome
- Cytomegalovirus Retinitis

## Interventions

- **DEVICE:** Sustained-Release Intraocular Drug Delivery System

## Key facts

- **NCT ID:** NCT00000118
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1992-10
- **Primary completion:** —
- **Final completion:** 1993-12
- **Target enrollment:** — (—)
- **Last updated:** 2009-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000118, "Ganciclovir Implant Study for Cytomegalovirus Retinitis". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00000118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
